Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Sep 9, 2026
4 Sep 4, 2026
4 Sep 4, 2026
4 Sep 4, 2026
4 Sep 4, 2026
4 Sep 4, 2026
4 Sep 4, 2026
4 Sep 4, 2026
4 Sep 4, 2026
S-8 Aug 12, 2026 FORM S-8
10-Q Aug 12, 2026 10-Q
8-K Aug 12, 2026 8-K
SCHEDULE 13G Jul 29, 2026
8-K Jun 25, 2026 8-K
8-K May 21, 2026 8-K
10-Q May 13, 2026 10-Q
8-K May 13, 2026 8-K
ARS Apr 30, 2026 ARS
DEF 14A Apr 30, 2026 DEF 14A
3/A Apr 27, 2026
SCHEDULE 13G/A Mar 30, 2026
10-K Mar 18, 2026 10-K
8-K Mar 18, 2026 8-K
8-K Mar 9, 2026 8-K
SCHEDULE 13G Mar 4, 2026
← Newer Page 1 of 38 · 935 filings Older →